Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 6, 2000, Pages 441-449

  Chie, L ^a,b   Amar, S ^a,b   Kung, H F ^c   Lin, M C M ^c   Chen, H ^c   Chung, D L ^a,b   Adler, V ^d   Ronai, Z ^d   Friedman, F K ^e   Robinson, R C ^e   Kovac, C ^a   Brandt Rauf, P W ^f   Yamaizumi, Z ^g   Michl, J ^h,i   Pincus, M R ^b,h  

^a LONG ISLAND UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Columbia School of Public Health ^*  (United States)

^g CANCER INSTITUTE   (Japan)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ Departments of Microbiol/Anat/C   (United States)

Author keywords

Dominant negative mutant of raf; Oncogenic ras p21; Oocyte maturation

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; INSULIN; MESSENGER RNA; MIDOSTAURIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN P21; RAS PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; NONHUMAN; ONCOGENE; OOCYTE MATURATION; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

ANIMALS; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; OOCYTES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 0034033611     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051017     Document Type: Article

References (35)

1. 1. Barbacid M (1987) ras Genes. Ann Rev Biochem 56: 779
2. 2. Birchmeier C, Broek D, Wigler M (1985) ras Proteins can induce meiosis in Xenopus oocytes. Cell 43: 615
3. 3. Deshpande AK, Kung H-F (1987) Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins. Mol Cell Biol 7: 1285
4. 4. Willumsen BM, Christensen A, Humbert NL, Papageorge AG, Lowy DR (1984) The p21 ras C-terminus is required for transformation and membrane association. Nature 310: 583
5. 5. Reiss Y, Goldstein JL, Seabra MC, Casey PJ, Brown MS (1990) Inhibition of purified p21-ras farnesyl-protein transferase by Cys-AAX tetrapeptides. Cell 62: 81
6. 6. Chardin P, Camonis JH, Gale NW, Van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D (1993) Human SOS1: a guanine nucleotide exchange factor for ras that binds to Grb2. Science 260: 1338
7. 7. Adari H, Lowy DR, Willumsen BF, Der CJ, McCormick F (1988) Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240: 518
8. 8. Moodie SA, Willumsen BM, Weber MJ, Wolfman A (1993) Complexes of ras-GTP with raf-1 and mitogen-activated protein kinase. Science 260: 1658
9. ras protein bind to the amino terminal regulatory domain of c-raf-1. Nature 364: 308
10. 10. Haspel J, Dent P, Haystead T, Brandt-Rauf PW, Chung D, Weinstein IB, Nishimura S, Yamaizumi Z, Pincus MR (1995) raf-Induced kinases may be necessary but are not sufficient for ras-p21 protein induction of oocyte maturation. Med Sci Res 23: 455
11. 11. Chung DL, Joran A, Friedman FK, Robinson RR, Brandt-Rauf PW, Weinstein IB, Ronai ZA, Baskin L, Dykes DC, Murphy RB, Nishimura S, Yamaizumi Z, Pincus MR (1992) Evidence that oocyte maturation induced by an oncogenic ras p21 protein and insulin is mediated by overlapping yet distinct mechanisms. Exp Cell Res 203: 329
12. 12. Chung DL, Brandt-Rauf PW, Weinstein IB, Nishimura S, Yamaizumi Z, Murphy RB, Pincus MR (1992) Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C. Proc Natl Acad Sci USA 89: 1993
13. 13. Meyer T, Regenass U, Fabbro D, Alteri E, Rosel J, Muller M, Caravatti G, Matter A (1989) A derivative of staurosporine (CPG 41 251) shows selectivity for protein kinase C inhibition and in vivo anti-tumor activity. Int J Cancer 43: 851
14. 14. Liwo A, Gibson KD, Scheraga HA, Brandt-Rauf PW, Monaco R, Pincus MR (1994) Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GDP or GTP. J Protein Chem 13: 237
15. 15. Monaco R, Chen JM, Friedman FK, Brandt-Rauf PW, Pincus MR (1995) Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins. J Protein Chem 14: 721
16. 16. Chen JM, Brandt-Rauf PW, Pincus MR (1996) Oncogenic amino acid substitutions in the inhibitory rap-1 A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics. J Biomol Struct Dyn 13: 925
17. 17. Adler V, Pincus MR, Brandt-Rauf PW, Ronai Z (1995) Complexes of ras-p21 with jun-N-kinase and c-jun proteins. Proc Natl Acad Sci USA 92: 10585
18. ras. J Biol Chem 271: 23304
19. 19. Ip YT, Davis, RJ (1998) Signal transduction by the c-jun N-terminal kinase (JNK) from inflammation to development. Opin Cell Biol 10: 205
20. 20. Glozman A, Amar S, Chung D, Adler V, Ronai Z, Brandt-Rauf PW, Nishimura S, Yamaizumi Z, Pincus MR (1996) Evidence that signal transduction by oncogenic ras-p21 protein depends on its interaction with jun kinase and jun proteins. Med Sci Res 24: 331
21. 21. Amar S, Glozman A, Chung DL, Alder V, Ronai Z, Friedman FK, Robinson R, Brandt-Rauf PW, Yamaizumi Z, Pincus MR (1997) Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents. Cancer Chemother Pharmacol 41: 79
22. 22. Pincus MR, Brandt-Rauf PW, Michl J, Friedman FK (1999) ras-p21-Induced cell transformation: unique signal transduction pathways and implications for the design of new chemotherapeutic agents. Cancer Invest (in press)
23. 23. Adler V, Yin Z, Fuchs S, Benezra M, Rosario L, Tew K, Pincus MR, Sardana M, Henderson C, Wolf CR, Davis R, Ronai Z (1999) GSTπ - a regulator of JNK signaling. EMBO J 18: 1321
24. 24. Villafania A, Anwar K, Amar S, Way D, Chung D, Adler V, Ronai Z, Brandt-Rauf PW, Yamaizumi Z, Kung H-F, Pincus, MR (1999) Glutathione-S-transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase. Ann Clin Lab Sci 30: 57
25. 25. Chung D, Villafania A, Anwar K, Amar S, Rijwani K, Kung H-F, Adler V, Ronai Z, Brandt-Rauf PW, Yamaizumi Z, Pincus MR (1998) Mutual dependence of jun-N-terminal kinase and protein kinase C on the oncogenic ras-p21 protein-induced mitogenic signaling pathway. Med Sci Res 26: 147
26. 26. Chen JM, Monaco R, Manolatos S, Brandt-Rauf PW, Friedman FK, Pincus MR (1997) Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1 A, bound to the ras-binding domain of the raf-p74 protein. Identification of effector domains in the raf protein. J Protein Chem 16: 619
27. 27. Chung D, Amar S, Glozman A, Chen JM, Friedman FK, Robinson R, Monaco R, Brandt-Rauf PW, Yamaizumi Z, Pincus MR (1997) Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras binding domain of the raf-p74 protein, identified from molecular dynamics calculations. J Protein Chem 16: 631
28. 28. Miura K, Inouye Y, Nakamori H, Iwai S, Ohtsuka E, Ikehara M, Noguchi S, Nishimura S (1986) Synthesis and expression of a synthetic gene for the activated human c-Ha-ros protein. Jpn J Cancer Res (Gann) 77: 45
29. 29. Xu R-H, Dong Z, Maeno M, Kim J, Suzuki A, Ueno N, Sredni D, Colburn NH, Kung H-F (1996) Involvement of Ras/Raf/ Ap-1 in BMP-4 signaling during Xenopus embryonic development. Proc Natl Acad Sci USA 93: 834
30. 30. LaBonne C, Burke B, Whitman M (1995) Role of MAP kinase in mesoderm induction and axial patterning during Xenopus development. Development 121: 1475
31. 31. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966
32. 32. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEK. Science 266: 1719
33. 33. Troppmair J, Bruder JT, App H, Cai H, Liptak L, Szeberenyi J, Cooper G, Rapp UR (1992) ras Controls coupling of growth factor receptors and protein kinase C in the membrane to raf-1 and B-raf protein serine kinases in the cytosol. Oncogene 7: 1867
34. 34. Ferrell JE, Machleder EM (1998) The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280: 895
35. 35. Karin M (1995) Regulation of activity by mitogen activated protein kinases. J Biol Chem 270: 16483